Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
56.29
+0.90 (1.62%)
At close: Sep 26, 2025, 4:00 PM EDT
56.50
+0.21 (0.37%)
After-hours: Sep 26, 2025, 5:02 PM EDT
Tarsus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Tarsus Pharmaceuticals stock ranges from a low of $51 to a high of $84. The average analyst price target of $67.14 forecasts a 19.28% increase in the stock price over the next year.
Price Target: $67.14 (+19.28%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2025.
Analyst Ratings
The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +27.91% | May 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $46 → $51 | Hold | Maintains | $46 → $51 | -9.40% | May 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $78 → $84 | Strong Buy | Maintains | $78 → $84 | +49.23% | May 2, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $54 → $58 | Strong Buy | Maintains | $54 → $58 | +3.04% | Mar 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $75 → $78 | Strong Buy | Maintains | $75 → $78 | +38.57% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
434.12M
from 182.95M
Increased by 137.28%
Revenue Next Year
620.10M
from 434.12M
Increased by 42.84%
EPS This Year
-1.46
from -3.07
EPS Next Year
1.63
from -1.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 459.0M | 750.8M | |||
| Avg | 434.1M | 620.1M | |||
| Low | 406.9M | 455.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 150.9% | 73.0% | |||
| Avg | 137.3% | 42.8% | |||
| Low | 122.4% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.72 | 2.65 | |||
| Avg | -1.46 | 1.63 | |||
| Low | -1.73 | 0.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.